The cardiovascular system is subject to hyperlipidaemic, inflammatory, and pro-oxidant
stressors. Over time, these factors drive prevalent chronic diseases, of which atherosclerosis …

The prognosis in systemic lupus erythematosus (SLE) has improved due to better treatment
and care, but cardiovascular disease (CVD) still remains an important clinical problem, since …

Brown bears (Ursus arctos) hibernate for 5–6 months during winter, but despite kidney
insufficiency, dyslipidemia and inactivity they do not seem to develop atherosclerosis or …

Introduction Chronic inflammatory diseases include cardiovascular disease (CVD),
atherosclerosis, rheumatic and autoimmune diseases, and others, constituting a large part of …

Atherosclerosis and its main consequence, cardiovascular disease (CVD) are nowadays
regarded as chronic inflammatory disease conditions, and CVD is the main cause of death …

Aims Antibodies against phosphorylcholine (anti-PC) are implicated as protection markers in
atherosclerosis, cardiovascular disease (CVD), and other chronic inflammatory conditions …

Objective Immunoglobulin M antibodies against phosphorylcholine (anti‐PC s) may be
protective in atherosclerosis, cardiovascular disease (CVD), and systemic lupus …

The risk of premature death is high among patients on haemodialysis (HD patients). We
previously determined that immunoglobulin (Ig) M antibodies against phosphorylcholine …

Background: We here study antibodies against phosphorylcholine (anti-PC) which we
reported to be inversely associated with atherosclerosis, cardiovascular disease (CVD), and …

This study showed that treatment with a therapeutic monoclonal immunoglobulin-G1
antibody against phosphorylcholine on oxidized phospholipids preserves coronary flow …